MDXH
MDxHealth SA
0.5652$
-2.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 90.8% | 77.3% | 76.0% | 67.2% | 73.1% | 76.1% | 72.5% | 88.7% | 24.5% | 29.6% | 42.5% | 36.1% | |
| 61.1% | 52.9% | 45.0% | 28.8% | 40.0% | 54.3% | 50.1% | 77.9% | 13.0% | 17.3% | 29.7% | 19.6% | |
| 61.1% | 52.9% | 45.0% | 28.8% | 40.0% | 54.4% | 50.1% | 78.0% | 13.1% | 17.3% | 29.7% | 19.6% | |
| 25.8% | 19.4% | 27.4% | 34.1% | 29.2% | 16.4% | 12.2% | 6.1% | 7.9% | 8.7% | 9.2% | 10.0% | |
| 2.8% | 2.5% | 2.2% | 3.3% | 2.8% | 2.9% | 7.3% | 2.5% | 2.0% | 2.2% | 2.5% | 4.6% | |
| – | – | – | 4.4% | 3.2% | 6.0% | 11.6% | 6.7% | 6.6% | – | – | – | |
| – | 2.0% | 1.7% | 2.0% | 1.7% | 0.0% | – | 0.0% | 30.2% | 27.8% | 22.8% | 26.3% | |
| 6.5% | 17.4% | 18.9% | 26.5% | 22.0% | 17.9% | 15.9% | 4.6% | 38.8% | 34.3% | 25.8% | 26.6% | |
| 23.2% | 23.3% | 22.1% | 25.6% | 20.4% | 51.5% | 81.6% | 37.5% | 92.2% | 94.4% | 90.6% | 108.2% | |
| 22.9% | 18.7% | 18.6% | 22.4% | 17.5% | 25.7% | 40.9% | 21.9% | 15.3% | 15.1% | 27.1% | 33.5% | |
| – | 0.8% | 0.6% | 0.6% | 0.4% | 3.0% | 11.2% | 7.0% | 1.5% | 1.6% | 1.1% | 1.3% | |
| 13.3% | 11.4% | 11.1% | 13.8% | 9.9% | 12.2% | 16.7% | 9.9% | 8.5% | 6.8% | 5.1% | 7.0% | |
| – | – | – | – | 0.0% | 22.3% | 32.3% | 10.2% | 29.3% | 27.5% | 32.4% | 51.5% | |
| 76.8% | 76.7% | 77.9% | 74.4% | 79.6% | 48.5% | 18.4% | 62.5% | 7.8% | 5.6% | 9.4% | -8.2% | |
| -229.9% | -148.3% | -145.9% | -189.8% | -219.2% | -459.4% | -675.9% | -325.4% | -242.0% | -256.7% | -234.9% | -272.4% | |
| 11.2% | 7.1% | 6.8% | 8.5% | 8.8% | 15.4% | 26.1% | 16.2% | 13.3% | 20.1% | 30.9% | 33.8% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.